Worse Neurological State During Acute Ischemic Stroke is Associated with a Decrease in Serum Albumin Levels
暂无分享,去创建一个
K. Rejdak | Beata Daniluk | E. Czekajska-Chehab | P. Kamieniak | H. Bartosik-Psujek | J. Bielewicz | J. Kurzepa
[1] J. Golmard,et al. S100B blood level measurement to exclude cerebral lesions after minor head injury: the multicenter STIC-S100 French study , 2014, Clinical chemistry and laboratory medicine.
[2] Jason K. W. Lee,et al. S100B as a Marker for Brain Damage and Blood–Brain Barrier Disruption Following Exercise , 2014, Sports Medicine.
[3] A. Munshi,et al. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. , 2013, Nutrition.
[4] N. Zhang,et al. Albumin induces neuroprotection against ischemic stroke by altering Toll-like receptor 4 and regulatory T cells in mice. , 2013, CNS & neurological disorders drug targets.
[5] A. Kisialiou,et al. Blood biomarkers role in acute ischemic stroke patients: higher is worse or better? , 2012, Immunity & Ageing.
[6] A. Obenaus,et al. Albumin therapy enhances collateral perfusion after laser-induced middle cerebral artery branch occlusion: a laser speckle contrast flow study , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] A. Słowik,et al. Serum albumin as a determinant of cortisol release in patients with acute ischemic stroke. , 2012, Atherosclerosis.
[8] R. Aquilani,et al. Supplementation of essential amino acids may reduce the occurrence of infections in rehabilitation patients with brain injury. , 2012, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.
[9] J. Valero,et al. Albumin attenuates DNA damage in primary-cultured neurons , 2009, Neuroscience Letters.
[10] Y. Funakoshi,et al. Serum S-100B protein levels in left- and right-hemisphere strokes , 2008, Journal of Clinical Neuroscience.
[11] A. Słowik,et al. Serum albumin level and nosocomial pneumonia in stroke patients , 2006, European journal of neurology.
[12] H. Milionis,et al. Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. , 2005, International journal of cardiology.
[13] A. Słowik,et al. Serum Albumin Level as a Predictor of Ischemic Stroke Outcome , 2004, Stroke.
[14] J Perl,et al. Serum S-100β as a possible marker of blood–brain barrier disruption , 2002, Brain Research.
[15] Weizhao Zhao,et al. Albumin Therapy of Transient Focal Cerebral Ischemia: In Vivo Analysis of Dynamic Microvascular Responses , 2002, Stroke.
[16] R. Sprengelmeyer,et al. S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. , 1997, Stroke.
[17] L. Parnetti,et al. Hemorheologic Factors in the Postacute Phase of Ischemic Stroke , 1988, Angiology.
[18] Feng-ling,et al. Enhanced Neuroprotection by Local Intra-Arterial Infusion of Human Albumin Solution and Local Hypothermia , 2013 .
[19] T. Sobrino,et al. Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke , 2009, Clinical chemistry and laboratory medicine.
[20] H. Liu,et al. Neovasculature and blood-brain barrier in ischemic brain infarct , 2004, Acta Neuropathologica.